The influence of the gut microbiome on polycystic ovary syndrome - literature review
DOI:
https://doi.org/10.12775/JEHS.2023.35.01.005Keywords
polycystic ovary syndrome, gut microbiome, microbiota, obesity, insulin resistance, hyperandrogenismAbstract
The intestinal microbiome is an integral part of our body, and a normal intestinal microflora allows the body to maintain homeostasis. Dysbiosis can contribute to the development of many cardiovascular diseases, can affect the development of cancer, gynecological diseases. Polycystic ovary syndrome affects many women of reproductive age and leads to a decrease in the quality of life of patients facing this problem. The main symptoms of PCOS are: menstrual disorders, problems with getting pregnant, skin problems (acne, hirsutism), obesity. The mainstay of treatment is hormonal medication, metformin. There are reports of supplementing drug therapy with diet, a healthy lifestyle. In recent years, there have been a number of studies looking for a relationship between the state of the intestinal microflora and polycystic ovary syndrome. In our work, we reviewed the available literature in the PuBMed database from 2019 to 2023 with key words on the studies related to our topic.
References
Yan S, Shouyang G, Cong Y, Weiliang Z. Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications: Front Cell Infect Microbiol. 2023; 13: 1142041.doi:10.3389/fcimb.2023.1142041. PMID:36909735; PMCID:PMC9998696.
Froment P, Plotton I, Giulivi C, Fabre S, Khoueiry R, Mourad NI. At the crossroads of fertility and metabolism: the importance of AMPK-dependent signaling in female infertility associated with hyperandrogenism. Human Reproduction, Volume 37, Issue 6, June 2022, Pages 1207–1228; doi.org/10.1093/humrep/deac067.
Hirschberg AL (2009). Zespół policystycznych jajników, otyłość i implikacje reprodukcyjne . dam https://journals.sagepub.com/doi/pdf/10.2217/WHE.09.39skie. Zdrowia (Londyn). 5 , 529-40; quiz 541-2. doi: 10.2217/WHE.09.39.
Luo Z, Wang L, Wang Y, Fan Y, Jiang L, Xu X. Impact of Insulin Resistance on Ovarian Sensitivity and Pregnancy Outcomes in Patients with Polycystic Ovary Syndrome Undergoing IVF:J Clin Med. 2023 Jan 19;12(3):818.
doi: 10.3390/jcm12030818. PMID:36769467; PMCID:PMC9918062.
Wang J, Zhou J, Gober HJ, Leung WT, Huang Z, Pan X, Li C. Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype:Biomed Pharmacother.2021 Jan;133:110958. doi:10.1016/j.biopha.2020.110958. Epub 2020 Nov 7. PMID: 33171400.
Fang-Fang He, Yu-Mei Li . Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review: J Ovarian Res.2020 Jun 17;13(1):73.doi: 10.1186/s13048-020-006703.PMID: 32552864; PMCID: PMC7301991.
Tremellen K, Pearce K.Dysbiosis of Gut Microbiota (DOGMA)--a novel theory for the development of Polycystic Ovarian Syndrome: Med Hypotheses.2012 Jul;79(1):104-12.doi: 10.1016/j.mehy.2012.04.016.Epub 2012 Apr 27. PMID:22543078.
Qi X, Yun C, Sun L, Xia J, Wu Q, Wang Y. Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome: Nat Med. 2019 Aug; 25(8): 1225–1233.doi:10.1038/s41591-019-0509-0.PMID: 31332392 ;PMCID: PMC7376369.
Duan L, An X, Zhang Y, Jin D, Zhao S, Zhou R. Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus:Biomed Pharmacother.2021 Oct;142:112094. doi:10.1016/j.biopha.2021.112094. Epub 2021 Aug 26. PMID: 34449321.
Guo Y, Qi Y, Yang X, Zhao L, Wen S, Liu Y. Association between Polycystic Ovary Syndrome and Gut Microbiota. Published: April 19, 2016;https://doi.org/10.1371/journal.pone.0153196.
Giampaolino P, Foreste V, Di Filippo C, Gallo A, Mercorio A, Serafino P. Microbiome and PCOS: State-of-Art and Future Aspects: Int J Mol Sci.2021 Feb; 22(4): 2048.Published online 2021 Feb 19.doi:10.3390/ijms22042048. PMID:33669557; PMCID: PMC7922491.
Chen W, Pang Y. Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites: Metabolites.2021 Dec 14;11(12):869.doi: 10.3390/metabo11120869.PMID: 34940628; PMCID: PMC8709086.
Gu Y, Zhou G, Zhou F, Li Y, Wu Q, He H. Gut and Vaginal Microbiomes in PCOS: Implications for Women's Health: Front Endocrinol (Lausanne). 2022 Feb 23;13:808508.doi: 10.3389/fendo.2022.808508. eCollection 2022. PMID: 35282446; PMCID: PMC8905243.
Rodrigues Paris V, Wong XYD, M Solon-Biet S, C EdwardsM, Aflatounian A, Gilchrist R. The interplay between PCOS pathology and diet on gut microbiota in a mouse model: Gut Microbes. 2022 Jan-Dec;14(1):2085961.doi: 10.1080/19490976.2022.2085961.PMID: 35787106; PMCID:PMC9450977.
Dong L, Hou X, Liu F, Tao H, Zhang Y, Zhao H. Regulation of insulin resistance by targeting the insulin-like growth factor 1 receptor with microRNA-122-5p in hepatic cells: Cell Biot Int. 2019 May;43(5):553-564. doi:10.1002/cbin.11129.Epub 2019 Apr 25. PMID: 30958584
M.Ervin S, Li Hao, Lim L, Lee R. Roberts, Xue Liang, Sridhar Mani. Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens:J Biol Chem.2019 Dec 6; 294(49): 18586–18599.
Published online 2019 Oct 21.doi:10.1074/jbc.RA119.010950. PMID:31636122; PMCID:PMC6901331
Zhang M, Hu R, Huang Y, Zhou F, Li F, Liu Z. Present and Future: Crosstalks Between Polycystic Ovary Syndrome and Gut Metabolites Relating to Gut Microbiota: Front Endocrinol (Lausanne).2022 Jul 19;13:933110.doi: 10.3389/fendo.2022.933110.eCollection 2022. PMID:35928893; PMCID:PMC9343597.
Fangfang He, Yumei Li.The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal-weight population:J Ovarian Res.2021 Mar 27;14(1):50.doi: 10.1186/s13048-021-00799-9.
PMID:33773586; PMCID:PMC8005233
Po-Kai Yang, Chia-Hung Chou, Chu-Chun Huang, Wen-Fen Wen, Hsin-fu Chen, Chia-Tung Shun, Obesity alters ovarian folliculogenesis through disrupted angiogenesis from increased IL-10 production:Mol Metab. 2021 Jul;49:101189. doi: 10.1016/j.molmet.2021.101189. Epub 2021 Feb 13. PMID:33592337; PMCID:PMC7933796.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Małgorzata Maria Cholewa, Magdalena Alicja Zapała, Monika Łapaj, Katarzyna Cichoń, Agata Kromer, Joanna Wilk, Julia Czarnota, Agnieszka Gawryś, Małgorzata Chyćko, Agnieszka Środoń

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 791
Number of citations: 0